Academic literature on the topic 'HIV Infections Hepatitis C'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'HIV Infections Hepatitis C.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "HIV Infections Hepatitis C"

1

YAN, Y. X., Y. Q. GAO, X. SUN, et al. "Prevalence of hepatitis C virus and hepatitis B virus infections in HIV-positive Chinese patients." Epidemiology and Infection 139, no. 3 (2010): 354–60. http://dx.doi.org/10.1017/s0950268810001597.

Full text
Abstract:
SUMMARYTo evaluate the prevalence of hepatitis C virus (HCV) and/or hepatitis B virus (HBV) infections in HIV-infected patients in China, an epidemiological serosurvey was conducted from May 2007 to September 2008 using a random cluster sampling design of infectious disease hospitals in seven high HIV-prevalent provinces (municipalities). Univariate analysis and logistic regression were used to study the determinants of HIV and HBV and/or HCV co-infection. The overall prevalence was 41·83% (95% CI 40·36–43·30) for anti-HCV and 12·49% (95% CI 11·50–13·48) for HBsAg, respectively. The prevalence
APA, Harvard, Vancouver, ISO, and other styles
2

Makuza, Jean Damascene, Marie Paul Nisingizwe, Jean Olivier Twahirwa Rwema, et al. "Role of unsafe medical practices and sexual behaviours in the hepatitis B and C syndemic and HIV co-infection in Rwanda: a cross-sectional study." BMJ Open 10, no. 7 (2020): e036711. http://dx.doi.org/10.1136/bmjopen-2019-036711.

Full text
Abstract:
ObjectivesThis study describes the burden of the hepatitis B, C and HIV co-infections and assesses associated risk factors.SettingThis analysis used data from a viral hepatitis screening campaign conducted in six districts in Rwanda from April to May 2019. Ten health centres per district were selected according to population size and distance.ParticipantsThe campaign collected information from 156 499 participants (51 496 males and 104 953 females) on sociodemographic, clinical and behavioural characteristics. People who were not Rwandan by nationality or under 15 years old were excluded.Prima
APA, Harvard, Vancouver, ISO, and other styles
3

BUREK, V., J. HORVAT, K. BUTORAC, and R. MIKULIĆ. "Viral hepatitis B, C and HIV infection in Croatian prisons." Epidemiology and Infection 138, no. 11 (2010): 1610–20. http://dx.doi.org/10.1017/s0950268810000476.

Full text
Abstract:
SUMMARYIncarcerated persons comprise about 0·4% of the Croatian population, of whom 25–30% misuse drugs. We attempted to determine the structure of the prison population, prevalence of HBV, HCV, HIV markers, co-infections with HBV, HCV and HIV and acute HBV, HCV and HIV infection. In total, 25·9% of prisoners were positive for some markers for viral hepatitis (HBV 11·3%, HCV 8·3%, HBV/HCV 6·3%). Prevalence of HBV infection in intravenous drug users (IDUs) was 26·2% (highly promiscuous group 20·4%, individuals with psychiatric diseases and personality disorders 16·0%). HCV infection in IDUs was
APA, Harvard, Vancouver, ISO, and other styles
4

Guo, Fuying, and Lingzhou Yang. "Research Progress on HIV/AIDS with Concomitant Hepatitis B Virus and/or Hepatitis C Virus Infection." Infection International 4, no. 1 (2015): 16–20. http://dx.doi.org/10.1515/ii-2017-0099.

Full text
Abstract:
Abstract Hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) involve similar transmission routes, namely, blood, sexual contact, and mother-baby contact. Therefore, HIV infection is usually accompanied by HBV and HCV infections. This observation poses a great challenge to the prevention and treatment of HIV/human acquired immunodeficiency syndrome (AIDS) accompanied by HBV and HCV infection. Highly active antiretroviral therapy (HAART) has been extensively applied. Hence, liverrelated diseases have become the main causes of complication and death in HIV-inf
APA, Harvard, Vancouver, ISO, and other styles
5

Dickson-Spillmann, Maria, Severin Haug, Ambros Uchtenhagen, Philip Bruggmann, and Michael P. Schaub. "Rates of HIV and Hepatitis Infections in Clients Entering Heroin-Assisted Treatment between 2003 and 2013 and Risk Factors for Hepatitis C Infection." European Addiction Research 22, no. 4 (2015): 181–91. http://dx.doi.org/10.1159/000441973.

Full text
Abstract:
Background/Aims: We report on the rates of hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) in 1,313 clients entering heroin-assisted treatment (HAT) in Switzerland from 2003 to 2013. We identify predictors of HCV infection. Methods: Data were collected using questionnaires within 2 weeks of clients' first entry into HAT. Prevalence of HAV, HBV, HCV and HIV was calculated using laboratory test results collected at entry or using reports of older test results. Predictors of HCV status were identified through multiple logistic regre
APA, Harvard, Vancouver, ISO, and other styles
6

Choy, Chiaw Yee, Li Wei Ang, Oon Tek Ng, Yee Sin Leo, and Chen Seong Wong. "Factors Associated with Hepatitis B and C Co-Infection among HIV-Infected Patients in Singapore, 2006–2017." Tropical Medicine and Infectious Disease 4, no. 2 (2019): 87. http://dx.doi.org/10.3390/tropicalmed4020087.

Full text
Abstract:
Co-infection of hepatitis B virus (HBV) and hepatitis C virus (HCV) with human immunodeficiency virus (HIV) is associated with increased risk of hepatic complications and mortality. A retrospective study to estimate the proportion of HBV and HCV co-infections in Singapore was conducted using a clinical database. We included 3065 patients who were seen under the Clinical HIV Programme at the largest referral centre for HIV care between 2006 and 2017 and were tested for both HBV and HCV. Factors associated with HIV-HBV and HIV-HCV co-infections were determined using logistic regressions. The maj
APA, Harvard, Vancouver, ISO, and other styles
7

TÁVORA, Lara Gurgel Fernandes, Elodie Bomfim HYPPOLITO, José Napoleão Monte da CRUZ, Nyvia Maria Barroso PORTELA, Samuel Montenegro PEREIRA, and Camila Monteiro VERAS. "HEPATITIS B, C AND HIV CO-INFECTIONS SEROPREVALENCE IN A NORTHEAST BRAZILIAN CENTER." Arquivos de Gastroenterologia 50, no. 4 (2013): 277–80. http://dx.doi.org/10.1590/s0004-28032013000400007.

Full text
Abstract:
ContextThe occurrence of HIV and hepatitis B (HBV) and C (HCV) virus associations is of great concern since co-infected patients respond poorly to antiviral treatment and usually progress to chronic and more complicated hepatic disease. In Brazil, these co-infections prevalence is not well known since published data are few and sometimes demonstrate conflicting results. Also, a significant number of co-infected individuals are HBV/HCV asymptomatic carriers, leading to under notification.ObjectivesThe present study aimed to determine the prevalence of the HBV and HCV infection in a recently dia
APA, Harvard, Vancouver, ISO, and other styles
8

Suman, Sonu. "Clinical, haematological, and biochemical profile of HIV patient co-infected with hepatitis B and /or C." International Journal of Research in Medical Sciences 8, no. 11 (2020): 3955. http://dx.doi.org/10.18203/2320-6012.ijrms20204885.

Full text
Abstract:
Background: Human immunodeficiency virus (HIV) positive population is at higher risk of getting infected with hepatitis B virus (HBV) or hepatitis C virus (HCV) or both. Co-infection with HBV/HCV may possibly complicate the clinical course of HIV in infected patients. Aim and objectives of the study were intended to determine clinical, haematological and biochemical profile of HIV patients co infected with hepatitis B and/or C.Methods: All consecutive patients presented with HIV infection who were coinfected with either Hepatitis B, C or both presenting to immunodeficiency or Gastroenterology
APA, Harvard, Vancouver, ISO, and other styles
9

Karim, AKM Rezaul, Afiqul Islam, Choudhury Yakub Jamal, et al. "Seroprevalence of Hepatitis B, Hepatitis C and Human Immunodeficiency Virus Among Multitransfused Thalassaemic Children in Dhaka, Bangladesh." Bangladesh Journal of Child Health 37, no. 3 (2014): 146–53. http://dx.doi.org/10.3329/bjch.v37i3.18618.

Full text
Abstract:
Background: Thalassaemia is a congenital hemolytic disease caused by defective globin chain synthesis of haemoglobin and largely treated by repeated blood transfusions. Transfusion-transmitted infections still make a great challenge in the management of patients with thalassaemia major. The most important worldwide transfusion transmitted infections (TTI) are hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Despite concern about a possible increase in the incidence of these infections there are no recent data about the prevalence of HBV, HCV and HIV from
APA, Harvard, Vancouver, ISO, and other styles
10

Biver, Emmanuel, Alexandra Calmy, and René Rizzoli. "Bone health in HIV and hepatitis B or C infections." Therapeutic Advances in Musculoskeletal Disease 9, no. 1 (2016): 22–34. http://dx.doi.org/10.1177/1759720x16671927.

Full text
Abstract:
Chronic infections with human immunodeficiency virus (HIV), hepatitis B virus (HBV) or hepatitis C virus (HCV) add to age-dependent bone loss and may contribute to lower bone strength in the elderly. In this review, we report recent highlights on the epidemiology of bone fragility in chronic viral infections with HIV, HCV and HBV, its physiopathology and discuss the interference of antiviral therapies with bone metabolism. Chronic infections influence bone through the interactions between risk factors for bone fragility and falls (which are highly prevalent in infected patients), virus activit
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "HIV Infections Hepatitis C"

1

Falconer, Karolin. "HIV-1/HCV co-infection immunity and viral dynamics /." Stockholm, 2010. http://diss.kib.ki.se/2010/978-91-7409-762-7/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Fialho, Renata. "Neuropsychiatric manifestations of hepatitis C treatment in HIV/HCV co-infection." Thesis, University of Sussex, 2017. http://sro.sussex.ac.uk/id/eprint/71260/.

Full text
Abstract:
Hepatitis C (HCV) infection is associated with high rates of mortality and morbidity. Interferon alpha based treatment for HCV offers a good rate of viral clearance, however the associated neuropsychiatric side effects increase the risk of treatment interruption and disease progression. The HIV/HCV coinfection is of particular interest due to association with higher rates of HCV treatment side effects and earlier treatment discontinuation when compared with HCV mono-infection. Therefore, the aim of the thesis was to further explore the effect of coinfection on mood and cognition and how HCV in
APA, Harvard, Vancouver, ISO, and other styles
3

Harris, Kathryn Ann. "Genetic diversity and evolution of hepatitis C virus." Thesis, Open University, 2000. http://oro.open.ac.uk/58053/.

Full text
Abstract:
Inter- and intra-host Hey variation was investigated. First. a polymerase chain reactionrestriction fragment length polymorphism procedure was used to assign genotypes and subtypes to Hey infecting 567 individuals (comprising haemophilia patients, blood donors, intravenous drug users, attenders of antenatal and genito-urinary medicine clinics and chronic liver disease patients) from England and Wales. The majority of infections were associated with types 3a, 1 a and 1 b, and genotype distributions were generally similar in different sub-populations. Only 1 % of individuals were identified as b
APA, Harvard, Vancouver, ISO, and other styles
4

Herreru-Martínez, Esteban. "Hepatitis C and HIV co-infection in patients with haemophilia." Thesis, University College London (University of London), 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.404936.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Burke, Stephanie. "Generalized Impairment of CD8+ T-cells in HCV Mono- and HIV-HCV Co-infection." Thesis, Université d'Ottawa / University of Ottawa, 2015. http://hdl.handle.net/10393/32770.

Full text
Abstract:
Chronic hepatitis C virus (HCV) infection has global effects on the immune system. CD8+ T-cells, responsible for viral clearance and control, are dysfunctional for as yet unknown reasons. It is hypothesized that IL-7 signaling pathway deficiencies contribute to this impairment. Blood-derived CD8+ T-cells in chronic HCV mono- and HIV-HCV co-infection had lower IL-7-induced activation of STAT5 and production of Bcl-2, and lower proliferation in co-infection, compared to controls. Lower Bcl-2 production was also associated with increased fibrosis. These changes were independent of the IL-7 recep
APA, Harvard, Vancouver, ISO, and other styles
6

Yao, Felix Caspar. "Investigation on the risk of viral infection in musculoskeletal grafts." University of Western Australia. School of Surgery, 2010. http://theses.library.uwa.edu.au/adt-WU2010.0068.

Full text
Abstract:
[Truncated abstract] Around 50,000 hip and knee replacements are performed every year in Australia and this number has been increasing by around 13% annually since 1998 (Transplantation Society 2006). The incidence and number of revision surgery has increased by a similar proportion. Autogenous bone or allograft is still the gold standard grafting material and is currently used in a variety of reconstructive surgical procedures. The use of any allograft material carries with it the risk of transfer of disease from donor to recipient. These tissues can transmit the same viral and bacterial infe
APA, Harvard, Vancouver, ISO, and other styles
7

Ogawa, Lisa Marie Fink. "Substance Use Experiences and Hepatitis C Treatment Decision-Making Among HIV/HCV Co-infected Adults: A Dissertation." eScholarship@UMMS, 2007. https://escholarship.umassmed.edu/gsn_diss/3.

Full text
Abstract:
Hepatitis C virus (HCV) infection affects between 150,000 to 300,000 human immunodeficiency (HIV) positive adults in the US (Alter et al., 1999; Sherman, Rouster, Chung, & Rajicic, 2002). The majority of co-infected adults (50%-90%) have acquired HCV through substance abuse (Centers for Disease Control [CDC], 1998; CDC, 2006b). A patient's decision to begin HCV treatment is not straightforward. HCV evaluation and treatment involves a significant amount of time, energy, effort, and compliance on the part of the patient. There is limited information on how adults with HCV mono-infection make dec
APA, Harvard, Vancouver, ISO, and other styles
8

Matsukura, Motoi. "Highly active anti-retroviral therapy and liver mitochondrial toxicity in human immunodeficiency virus / hepatitis C virus co-infection." Thesis, University of British Columbia, 2008. http://hdl.handle.net/2429/2517.

Full text
Abstract:
Background: A third of HIV-infected patients are co-infected with HCV in the developed world, and more of co-infected patients than ever before are dying because of liver related diseases today. Drug-related hepatotoxicity is a growing concern among human immunodeficiency virus (HIV) / hepatitis C virus (HCV) co-infected population. Nucleotide analogues containing HIV antiretroviral therapy, namely highly active anti-retroviral therapy (HAART), can induce mitochondrial toxicity. However, little is known about the effect of nucleotide analogues on the liver at the cellular and molecular level,
APA, Harvard, Vancouver, ISO, and other styles
9

Malm, Kerstin. "Diagnostic strategies for blood borne infections in Sweden." Doctoral thesis, Örebro universitet, Institutionen för hälsovetenskap och medicin, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-44303.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Chen, Yang. "An Epidemiological Study of Hepatitis C Virus Infection Among U.S. Population." Digital Commons @ East Tennessee State University, 2016. https://dc.etsu.edu/etd/3105.

Full text
Abstract:
Hepatitis C virus (HCV) infection is the most common blood-borne infection in the United States (U.S.). The largest increases of incidence for HCV infection are reported in the Appalachian region. This study aimed to 1) examine the prevalence and trends of HCV infection in the U.S. from 1999 to 2012; 2) investigate barriers to HCV infection treatment in Northeast Tennessee and the U.S.; and 3) study characteristics and risk factors for HIV-infection and HCV-infection in Northeast Tennessee. In the U.S., data were obtained from the National Health and Nutrition Examination Survey (NHANES) 1999-
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "HIV Infections Hepatitis C"

1

Saskatchewan Subcommittee on HIV/AIDS. Guidelines for the management of potential exposures to Hepatitis B, Hepatitis C, HIV, and recommendations for post-exposure prophyalxis. Saskatchewan Health, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

San Francisco (Calif.). Dept. of Public Health. Communicable Disease Control Unit. Registry match: Chronic hepatitis B, hepatitis C infection and HIV : 2010, San Francisco, California. San Francisco Department of Public Health, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Thiemann, Lillian. Double jeopardy: The HIV/HCV co-infection handbook. Community Prescription Service, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Trinity, College (Dublin Ireland) Dept of Community Health and General Practice. Hepatitis B, hepatitis C, and HIV in Irish prisoners, part II: Prevalence and risk in committal prisoners 1999 : report prepared for the Minister for Justice, Equality, and Law Reform. Stationary Office?, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Tribunal of Inquiry into the Infection with HIV and Hepatitis C of Persons with Haemophilia and Related Matters. Report of the Tribunal of Inquiry into the Infection with HIV and Hepatitis C of Persons with Haemophilia and Related Matters. Stationery Office, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ruiz, Juan D. Seroprevalence of HIV, hepatitis B, hepatitis C, and risk behaviors among inmates entering the California correctional system. California Dept. of Health Services, Office of Aids, HIV/AIDS Epidemiology Branch, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Jürgens, Ralf. HIV/AIDS and HCV in prisons: A select annotated bibliography. International Affairs Directorate, Health Canada, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Swan, Tracy. Care and treatment for hepatitis C and HIV coinfection: Expanding access through the Ryan White CARE Act. U.S. Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ireland. Hepatitis C Compensation Tribunal. Annual report of the Hepatitis C Compensation Tribunal. Stationery Office, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Association, American Nurses. HIV, Hepatitis-B, Hepatitis-C: Blood-borne diseases; nurses' risks, rights, and responsibilities. ANA, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "HIV Infections Hepatitis C"

1

Carlin, Joseph, Maria Cassia Mendes-Correa, and Marina Núñez. "Hepatitis B and C." In Sexually Transmitted Infections in HIV-Infected Adults and Special Populations. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56694-8_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Young, Hugh, and Marie Ogilvie. "Hepatitis C virus (HCV) (Non-A, Non-B hepatitis)." In Genitourinary Infections. Springer Netherlands, 1994. http://dx.doi.org/10.1007/978-94-017-5080-6_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Matthews, Gail V., and Gregory J. Dore. "HIV and Hepatitis C Co-Infection." In Advanced Therapy for Hepatitis C. Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781444346343.ch22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Rauch, Andri, and Jürgen Kurt Rockstroh. "Hepatitis C Virus Infection and HIV." In Encyclopedia of AIDS. Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4614-9610-6_426-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Rauch, Andri, and Jürgen Kurt Rockstroh. "Hepatitis C Virus Infection and HIV." In Encyclopedia of AIDS. Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-7101-5_426.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Marcelin, Jasmine Riviere, Lynda A. Szczech, and Stacey Rizza. "Glomerular Diseases Associated with HIV, Hepatitis B, and Hepatitis C Infections." In Core Concepts in Parenchymal Kidney Disease. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-8166-9_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Presterl, Elisabeth, Magda Diab-El Schahawi, Luigi Segagni Lusignani, Helga Paula, and Jacqui S. Reilly. "Blood-Borne Viruses: HIV, Hepatitis B, and Hepatitis C." In Basic Microbiology and Infection Control for Midwives. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-030-02026-2_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Persidsky, Yuri, Wen-Zhe Ho, Xu Wang, and Raghava Potula. "Alcohol Abuse, HIV-1, and Hepatitis C Infection." In Neural-Immune Interactions in Brain Function and Alcohol Related Disorders. Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-4729-0_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Terrault, Norah. "Liver Transplantation in Patients with Hepatitis B, C or HIV Infection." In Sherlock's Diseases of the Liver and Biliary System. Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781444341294.ch37.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Luckett, Keith, and Stephen Dummer. "Monitoring and Management of Hepatitis B, Hepatitis C, and HIV Infection before and after Transplantation." In Blood and Marrow Transplantation Long-Term Management. John Wiley & Sons, Ltd, 2013. http://dx.doi.org/10.1002/9781118473306.ch29.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "HIV Infections Hepatitis C"

1

Shah, Neil J., Ghassan AL-Shbool, Matthew Blackburn, et al. "Abstract 3230: Safety and efficacy of immune checkpoint inhibitors (ICIs) in patients with HIV, hepatitis B, or hepatitis C viral infections." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-3230.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Shah, Neil J., Ghassan AL-Shbool, Matthew Blackburn, et al. "Abstract 3230: Safety and efficacy of immune checkpoint inhibitors (ICIs) in patients with HIV, hepatitis B, or hepatitis C viral infections." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-3230.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Butov, Dmytro, Mykhailo Kuzhko, Mykola Gumeniuk, Oleksiy Denysov, Tetiana Sprynsian, and Tetiana Butova. "Features the effectiveness of the treatment of moxifloxacin in patients with co-infections tuberculosis/HIV and hepatitis B,and/or C." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.484.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sow, P. "P432 The prevalence of co-infection with HIV, Hepatitis C and TB among patients infected by HIV/AIDS in Senegal." In Abstracts for the STI & HIV World Congress, July 14–17 2021. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/sextrans-2021-sti.452.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Fischer, William A., Michael B. Drummond, Christian A. Merlo, et al. "Association Between Markers Of Hepatitis C Infection And Obstructive Lung Disease In A Population At-Risk Or With HIV Infection." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4055.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Paschoini, MC, LN Resende, MM Mendonça, GPM Gomide, and JU Ribeiro. "P3.181 Hepatitis c: challenging modern obstetrics." In STI and HIV World Congress Abstracts, July 9–12 2017, Rio de Janeiro, Brazil. BMJ Publishing Group Ltd, 2017. http://dx.doi.org/10.1136/sextrans-2017-053264.416.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Schmidt, Axel. "S03.4 Hepatitis C in HIV-negative MSM – a growing concern?" In Abstracts for the STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI), July 14–17, 2019, Vancouver, Canada. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/sextrans-2019-sti.27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Al-absi, Enas, Nadima Haj Ali, Aisha Khan, et al. "Infection Rates And Phylogenetic Analysis Of Hepatitis G Virus (hgv)/gb Virus C (gbv-c) Among Qatari Blood Donors." In Qatar Foundation Annual Research Conference Proceedings. Hamad bin Khalifa University Press (HBKU Press), 2014. http://dx.doi.org/10.5339/qfarc.2014.hbop0582.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Al-Kubaisy, Waqar, Suzanna Daud, Mustafa Waseem Al-Kubaisy, Omar Waseem AL-Kubaisy, and NikNairan Abdullah. "MATERNAL HEPATITIS C (HCV) INFECTION AND ANTI-D IMMUNOGLOBULIN THERAPY: STUDY TESTING ANTIBODIES, RNA AND GENOTYPE OF HCV IN BAGHDAD." In THE 2ND INTERNATIONAL CONFERENCE ON PUBLIC HEALTH. Masters Program in Public Health, Graduate School, Sebelas Maret University Jl. Ir Sutami 36A, Surakarta 57126. Telp/Fax: (0271) 632 450 ext.208 First website:http//: pasca.uns.ac.id/s2ikm Second website: www.theicph.com. Email: theicph2017@gmail.com, 2017. http://dx.doi.org/10.26911/theicph.2017.020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Nienhaus, A., C. Westermann, and M. Dulon. "1603a Costing occupational infections: lessons from hepatitis c in health workers in germany." In 32nd Triennial Congress of the International Commission on Occupational Health (ICOH), Dublin, Ireland, 29th April to 4th May 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/oemed-2018-icohabstracts.590.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "HIV Infections Hepatitis C"

1

Saraswati, Lopamudra, Mary Sebastian, Avina Sarna, et al. Prevalence of HIV, hepatitis B and C, and co-infection in a cohort of male injection drug users in Delhi. Population Council, 2013. http://dx.doi.org/10.31899/hiv10.1001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Buresh, Christopher. The Opioid Epidemic in Iowa and the Connection to Hepatitis C and HIV Outbreaks. University of Iowa Public Policy Center, 2019. http://dx.doi.org/10.17077/rep.001111.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Mark, Tami L., William N. Dowd, and Carol L. Council. Tracking the Quality of Addiction Treatment Over Time and Across States: Using the Federal Government’s “Signs” of Higher Quality. RTI Press, 2020. http://dx.doi.org/10.3768/rtipress.2020.rr.0040.2007.

Full text
Abstract:
The objective of this study was to track trends in the signs of higher-quality addiction treatment as defined by the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Addiction, and the Substance Abuse and Mental Health Services Administration. We analyzed the National Survey of Substance Abuse Treatment Services from 2007 through 2017 to determine the percent of facilities having the characteristics of higher quality. We analyzed the percent by state and over time. • We found improvements between 2007 and 2017 on most measures, but performance on several measures r
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!